Neuregulin-1NeuregulinsReceptor, erbB-3Receptor, erbB-2Receptor, Epidermal Growth FactorBreastPrognosisBreast NeoplasmsTumor Markers, BiologicalCarcinoma, Ductal, BreastReceptors, EstrogenSurvival AnalysisNeoplasm StagingEpidermal Growth FactorPredictive Value of TestsCell Line, TumorGenes, erbBGene Expression Regulation, NeoplasticSurvival RateDisease-Free SurvivalFollow-Up StudiesReceptors, ProgesteroneNeoplasm InvasivenessNeoplasm MetastasisMultivariate AnalysisTamoxifenBreast DiseasesRetrospective StudiesImmunohistochemistryRisk FactorsKaplan-Meier EstimateProspective StudiesLymphatic MetastasisProportional Hazards ModelsMammographyNeoplasm ProteinsTreatment OutcomeNeoplasm Recurrence, LocalAntineoplastic AgentsChemotherapy, AdjuvantBreast Neoplasms, MaleRisk AssessmentAntineoplastic Agents, HormonalAntineoplastic Combined Chemotherapy ProtocolsCarcinomaTime FactorsDisease ProgressionMastectomyLung NeoplasmsCarcinoma, LobularGene Expression ProfilingCohort StudiesEarly Detection of CancerOvarian NeoplasmsKi-67 AntigenGenes, erbB-2PostmenopauseCase-Control StudiesGenes, BRCA1Reverse Transcriptase Polymerase Chain ReactionTissue Array AnalysisDrug Resistance, NeoplasmSensitivity and SpecificityAge FactorsCarcinoma, Intraductal, NoninfiltratingCell ProliferationTumor Cells, CulturedMice, NudeRNA, MessengerGenetic Predisposition to DiseaseMCF-7 CellsAdenocarcinomaEstrogen Receptor alphaRiskDNA, NeoplasmNeoplasms, Hormone-DependentMammary Neoplasms, ExperimentalProstatic NeoplasmsPremenopauseBreast FeedingEstrogensNeoplasm GradingMutationSignal TransductionStomach NeoplasmsTumor Suppressor Protein p53MenopauseIncidenceOdds RatioNeoplasmsAxillaBreast Self-ExaminationLymph NodesCombined Modality TherapyReproducibility of ResultsImmunoenzyme TechniquesBRCA2 ProteinBiological MarkersBlotting, WesternBone Neoplasms